Radiotherapy combined with bevacizumab in gastrointestinal cancers: Balancing efficacy against the risk of intestinal perforation
{{output}}
The combination of radiotherapy with bevacizumab represents a promising therapeutic strategy for advanced gastrointestinal cancers. While this combination leverages synergistic mechanisms to enhance antitumor efficacy, it also poses significant safety concerns... ...
